Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
E3 ubiquitin-protein ligase TRIM68 is a member of the tripartite motif-containing (TRIM) protein family, characterized by the presence of a RING finger domain, B-box motif, and a coiled-coil region[1][5][8]. TRIM68 acts as an E3 ubiquitin ligase, catalyzing the transfer of ubiquitin to substrate proteins, thereby regulating their stability and activity[1][2][5]. It serves as a coactivator of nuclear receptors, most notably the androgen receptor, facilitating transcriptional activation in a ubiquitin-dependent manner[1][2][4]. TRIM68 is highly expressed in prostate tissue and is upregulated in androgen-dependent prostate cancer cells, suggesting a role in cancer biology and hormone signaling[3]. Additionally, TRIM68 contributes to regulation of the innate immune response by negatively controlling the production of type I interferons and possibly modulating antiviral and inflammatory signaling pathways[5]. Alternative splicing results in multiple transcript variants encoding different isoforms[1]. Diseases associated with TRIM68 include prostate cancer, lupus erythematosus, and cataract[1]. Note: No small molecule drugs or antibodies are currently documented as direct modulators of TRIM68 in public databases or literature. Its clinical utility as a direct therapeutic target requires more research.
Ubiquitin-proteasome pathway modulation via E3 ligase activity; Modulation of nuclear receptor-mediated transcription (notably androgen receptor); Downregulation of interferon signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM68 (TRIM68).